Advancements TV Series presentation

We invite you to learn more about our organization and lead compound, BXQ-350 through our recent Advancements TV Series Presentation

Other Videos

  • Chemotherapy Induced Peripheral Neuropathy (CIPN)

  • Immunostimulating Properties of BXQ-350

  • Tolerability and Preliminary Efficacy of BXQ-350 for Solid Tumors and Gliomas: First-in-human, first-in-class phase 1 trial

  • Comprehensive Investor Presentation

  • Bexion Pharmaceuticals Corporate Video

  • Bexion Highlight Reel

  • Alpha Summit Presentation

  • 3rd Annual Glioblastoma Drug Development Presentation

  • Advancements TV Series presentation

  • BXQ-350: Stimulating the Immune System by Modulating Phosphatidylserine Expression and Sphingolipid Signaling

    UCSF Awards Video

  • Dr. Rixe Video – BXQ-350 MOA